Corticosteroid-releasing cochlear implant: A novel hybrid of biomaterial and drug delivery system

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 94, Issue 2, 2010, Pages 388-398

  Ghavi, Farhid Farahmand ^a   Mirzadeh, Hamid ^a   Imani, Mohammad ^a   Jolly, Claude ^b   Farhadi, Mohammad ^c  

^a IRAN POLYMER AND PETROCHEMICAL INSTITUTE   (Iran)

^b MED EL GmbH   (Austria)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cochlear implant; Dexamethasone; Drug delivery; Release profile; Silicone rubber

Indexed keywords

BIOLOGICAL MATERIALS; DRUG DELIVERY; DRUG PRODUCTS; ELASTOMERS; FUNCTIONAL POLYMERS; LOADING; RUBBER; SILICONES;

COCHLEAR IMPLANT; DEXAMETHASONE; DEXAMETHASONES; RELEASE PROFILES; SILICONE RUBBER;

COCHLEAR IMPLANTS;

BIOMATERIAL; DEXAMETHASONE; ELASTOMER; SILICONE; CORTICOSTEROID; SODIUM CHLORIDE;

ARTICLE; COCHLEA PROSTHESIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG DELIVERY SYSTEM; DRUG INDICATION; DRUG RELEASE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; POSTOPERATIVE INFLAMMATION; REPRODUCIBILITY; BIOLOGICAL MODEL; COCHLEAR IMPLANTATION; ELECTRODE; EVALUATION STUDY; INFLAMMATION; PROCEDURES;

ADRENAL CORTEX HORMONES; BIOCOMPATIBLE MATERIALS; COCHLEAR IMPLANTATION; COCHLEAR IMPLANTS; DEXAMETHASONE; DRUG DELIVERY SYSTEMS; ELECTRODES; INFLAMMATION; MODELS, BIOLOGICAL; SODIUM CHLORIDE;

EID: 77955361384     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31666     Document Type: Article

References (56)

1. Mikos AG, Murphy R, Bernstein H, Peppas NA, editors. Biomaterials for Drug and Cell Delivery. Pittsburgh: Materials Research Society; 1994.
2. Domb AJ. Polymeric Site-Specific Pharmacotherapy. Chichester, UK: Wiley; 1994.
3. Popovic N, Brundin P. A Mini review: Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases. Int J Pharm 2006;314:120-126.
4. Chien YM. Novel Drug Delivery System, Vol. 14. USA: Marcel Dekker; 1992.
5. Benoit JP, Faisant N, Venier-Julienne MC, Menei P. Development of microspheres for neurological disorders: From basic to clinical applications. J Controlled Release 2000;65:285-296.
6. Walline KS. Drug Delivery Coatings for Cardiovascular Stents: Silicone Elastomer and Thrombin Responsive Hydrogel Coatings. Washington: University of Washington; 2004.
7. Farrell S, Hesketh RP. An introduction to drug delivery for chemical engineers. Chem Eng Educ 2002;36:198-203.
8. Webster JG, editor. Encyclopedia of Medical Devices and Instrumentation, 2nd ed., New York, USA: Wiley; 2006.
9. Clark G. Cochlear Implants: Fundamentals and Applications. New York: Springer-Verlag; 2003.
10. Christiansen JB, Leigh IW. Cochlear Implants in Children: Ethics and Choices. Washington, DC: Gallaudet University Press; 2002.
11. Waltzman SB, Roland JT. Cochlear Implant: In: Cohen NL, Roland JT, editors. Complications of Cochlear Implant Surgery, 2nd ed. USA: Thieme Medical Publisher; 2006, Chapter 10, p. 126-127.
12. Hoep LS, Merkus P, Schie AV, Rinkel R, Smit CF. The value of nuclear scans in cochlear implant infections. Eur Arch Otorhinolaryngol 2006;263:895-899.
13. Lanotte P, Watt S, Ruimy R, Boiron P, Robier A, Quentin R. Nocardia farcinica Infection of a cochlear implant in an immunocompetent boy. Eur J Clin Microbiol Infect Dis 2001;20:880-882.
14. Kaila R, Evans RA. Cochlear implant infection due to cholesteatoma. Cochlear implant Int 2005;6:141-146.
15. Lustig LR, Niparko JK, Minor LB. Clinical Neurotology: Diagnosing and Managing Disorders of Hearing, Balance and the Facial Nerve. UK: Martin Dunitz Ltd; 2003.
16. Brackmann DE, Shelton C, Arriaga MA. Otologic Surgery, 2nd ed. USA: Saunders Company; 2001.
17. Madell JR, Flexer C. Pediatric Audiology: Diagnosis, Technology and Management. USA: Thieme Medical Publisher; 2008.
18. Chute PM, Nevins ME. The Parents' Guide to Cochlear Implants. Washington, DC: Gallaudet University Press; 2002.
19. Hughes GB, Pensak ML. Clinical Otology, 3rd ed. USA: Thieme Medical Publisher; 2007.
20. Wiet RJ. Ear and temporal bone surgery: Minimizing risks and complications. In: Cohen NL, Marrinan MS, editors. Avoiding Complications of Cochlear Implant Surgery. USA: Thieme Medical Publisher; 2006, Chapter 10, p 102-103.
21. James DP, Eastwood H, Richardson RT. Effects of round window dexamethasone on residual hearing in a guinea pig model of cochlear implantation. Audiol Neurotol 2008;13:86-96.
22. Gersema L, Baker K. Use of corticosteroids in oral surgery. J Oral Maxillofac Surg 1992;50:270-277.
23. Rathbone MJ. Modified-Release Drug Delivery Technology (Drugs and the Pharmaceutical Sciences), 2nd ed., Vol. 2. USA: Informa Heaithcare; 2008.
24. Salt AN. Pharmacokinetics of drug entry into cochlear fluids. Volta Rev 2005;105:277-298.
25. Bacigalupo A, Palandri F. Management of acute graft versus host disease (GvHD). Hematol J 2004;5:189-196.
26. Van De Water TR, Dinh CT, Vivero R, Hoosien G, Eshraghi AA, Balkany TJ. Mechanisms of hearing loss from trauma and inflammation: Otoprotective therapies from the laboratory to the clinic. Acta Otolaryngol 2009;4:1-4.
27. Vivero RJ, Joseph DE, Angeli S, He J, Chen S, Eshraghi AA, Balkany TJ, Van De Water TR. Dexamethasone base conserves hearing from electrode trauma-induced hearing loss. Laryngoscope 2008;118:2028-2035.
28. Dinh CT, Haake S, Chen S, Hoang K, Nong E, Eshraghi AA, Balkany TJ, Van De Water TR. Dexamethasone protects organ of corti explants against tumor necrosis factor-alpha-induced loss of auditory hair cells and alters the expression levels of apoptosisrelated genes. Neuroscience 2008;157:405-413.
29. Carrasco VN, Pillsbury HC. Revision Otologic Surgery. USA: Thieme Medical Publisher; 1997. pp 97-98.
30. Ye Q, Kiefer J, Klinke R, Gstoettner W, Tillein J. The effect of corticosteroid on the preservation of hearing in cochlear implanted Guinea Pigs, Presented at the 28th Annual Midwinter Research Meeting Association for Research in Otolaryngology, New Orleans, Louisiana, February 19-24, 2005.
31. Hochmair I, Nopp P, Jolly C, Schmidt M, Schößer H, Garnham C, Anderson I. MED-EL cochlear implants: State of the art and a glimpse into the future. Trends Amplif 2006;10:201-220.
32. Paasche G, Gibson P, Averbeck T, Becker H, Lenarz T, Stöver T. Technical report: Modification of a cochlear implant electrode for drug delivery to the inner ear. Otol Neurotol 2003;24:222-227.
33. Paasche G, Bogel L, Leinung M, Lenarz Y, Stöver T. Substance distribution in a cochlea model using different pump rates, Presented at the 28th Annual Midwinter Research Meeting Association for Research in Otolaryngology, Vol. 28, New Orleans, Louisiana, February 19-24, 2005. p 38.
34. Paasche G, Bogel L, Leinung M, Lenarz Y, Stöver T. Substance distribution in a cochlea model using different pump rates for cochlear implant drug delivery electrode prototypes. Hear Res 2006;212:74-82.
35. Kuzma JA, Lenarz THR, Battmer R, Mann AE. Cochlear electrode with drug delivery channel and method of making same. U.S. Pat. 6,309,410, 2001.
36. Prieskorn D, Miller J. Technical report: Chronic and acute intracochlear infusion in rodents. Hear Res 2000;140:212-215.
37. Granham C, Reetz G, Jolly C, Miller J, Salt A, Beal F. Drug delivery to the cochlea after implantation: Consideration of the risk factors, Proceedings of the 4th International Symposium on Electronic Implants in Otology, France, 2003.
38. Johnson TA, Loeffler KA, Burne RA, Jolly CN, Antonelli PJ. Biofilm formation in cochlear implants with cochlear drug delivery channels in an in vitro model. Otolaryngol Head Neck Surg 2007;136:577-582.
39. http://www.nusil.com/library/products/MED-4244P.pdf, December 2009.
40. http://cdsco.nic.in/html/BULK-DRUGS4.htm, December 2009.
41. British Pharmacopoeia, Vol. 3. Appendix IIB. Stationary Office, A121-A123, UK: London, 1999.
42. Validation of analytical methods in accordance with ICH guidelines Q2 (R1), Validation of analytical procedures: Text and methodology, http://www.bioforum.org.il/Uploads/Editor/karen/q2-r1-step4.pdf.
43. Sigma, Product Information, Dexamethasone crystalline, http://www.sigmaaldrich.com/catalog/ProductDetail.
44. Brittain H. Analytical profiles of drug substances, and excipients. In: Cohen EM, editor, Dexamethasone, USA: Elsevier. pp 163-197.
45. Hahn H, Kammerer B, Dimauro A, Salt AN, Plontke SK. Cochlear microdialysis for quantification of dexamethasone and fluorescein entry into scala tympani during round window administration. Hear Res 2006;212:236-244.
46. Hickey T, Kreutzer D, Burgess DJ, Moussya F. Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices. Biomaterials 2002;23:1649-1656.
47. Eljarrat-Binstock E, Raiskup F, Frucht-Pery J, Domb AJ. Transcorneal and transscleral iontophoresis of dexamethasone phosphate using drug loaded hydrogel. J Controlled Release 2005;106:386-390.
48. Baker RW. Controlled Release of Biologically Active Agents. USA: Wiley; 1987.
49. Chandrasekhar SS. Intratympanic dexamethasone for sudden sensorineural hearing loss: Clinical and laboratory evaluation. Otol Neurotol 2001;22:18-23.
50. Parnes LS, Sun AH, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: An animal study followed by clinical application. Laryngoscope 1999;109:1-17.
51. Salt NA. Dexamethasone concentration gradients along scala tympani after application to the round window membrane. Otol Neurotol 2008;29:401-406.
52. Jahn AF, Sacchi JS. Physiology of the Ear, 2nd ed. Canada: Singular Thomson Learning; 2001.
53. Troy DB, Ding X, Alani AW, Robinson JR, editors. Extended Release and Targeted Drug Delivery Systems, 21st ed. USA: Lippincott Williamas & Wilkins; 2006.
54. Dingni MN. Drug release coating stent. Eur Pat. EP0822788, 09/04/2002.
55. Bhatt PP, Raul VA. Method of controlling release of an active or drug from a silicone rubber matrix. U.S. Pat. 5,597,584, 1997.
56. Organized by Crain Communications Limited, Jerschow DP. New developments in silicone rubber technology-properties, processing and applications, Materials paper7, '99 Rubber Conference: GMex Centre, Manchester: June 7/8/9 and 10: The International Rubber Exhibition and Conference, Manchester, UK, 2007.